These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 36693363)

  • 1. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
    Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
    Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms.
    Machado I; Agaimy A; Giner F; Navarro S; Michal M; Bridge J; Claramunt R; López-Guerrero JA; Alcacer J; Linos K; Llombart-Bosch A
    Virchows Arch; 2024 May; 484(5):765-775. PubMed ID: 37940743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLI1 Coamplification in Well-Differentiated/Dedifferentiated Liposarcomas: Clinicopathologic and Molecular Analysis of 92 Cases.
    Sharma AE; Dickson M; Singer S; Hameed MR; Agaram NP
    Mod Pathol; 2024 Jun; 37(6):100494. PubMed ID: 38621503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
    Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
    Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive Nested Glomoid Neoplasm: Clinicopathologic Analysis of 20 Cases of a Mesenchymal Neoplasm With Frequent GLI1 Alterations and Indolent Behavior.
    Papke DJ; Dickson BC; Oliveira AM; Sholl LM; Fletcher CDM
    Am J Surg Pathol; 2023 Jan; 47(1):12-24. PubMed ID: 36395474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
    Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
    Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.
    Baranov E; Black MA; Fletcher CDM; Charville GW; Hornick JL
    Mod Pathol; 2021 Jul; 34(7):1367-1372. PubMed ID: 33731886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Nov; 29(11):1324-1334. PubMed ID: 27443513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed Death Ligand 1 (PD-L1) Expression in Malignant Mesenchymal Tumors.
    Kösemehmetoğlu K; Özoğul E; Babaoğlu B; Tezel GG; Gedikoğlu G
    Turk Patoloji Derg; 2017; 1(1):192-197. PubMed ID: 28832074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis.
    Kerr DA; Cloutier JM; Margolis M; Mata DA; Rodrigues Simoes NJ; Faquin WC; Dias-Santagata D; Chopra S; Charville GW; Wangsiricharoen S; Lazar AJ; Wang WL; Rosenberg AE; Tse JY
    Mod Pathol; 2024 Feb; 37(2):100386. PubMed ID: 37992966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Malignant Neoplasm From the Jejunum With a
    Prall OWJ; McEvoy CRE; Byrne DJ; Iravani A; Browning J; Choong DY; Yellapu B; O'Haire S; Smith K; Luen SJ; Mitchell PLR; Desai J; Fox SB; Fellowes A; Xu H
    Int J Surg Pathol; 2020 Aug; 28(5):553-562. PubMed ID: 31931637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the spectrum of GLI1-altered mesenchymal tumors-A high-grade uterine sarcoma harboring a novel PAMR1::GLI1 fusion and literature review of GLI1-altered mesenchymal neoplasms of the gynecologic tract.
    Punjabi LS; Goh CHR; Sittampalam K
    Genes Chromosomes Cancer; 2023 Feb; 62(2):107-114. PubMed ID: 36222065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLI1-Altered Mesenchymal Tumors.
    Cloutier JM; Kerr DA
    Surg Pathol Clin; 2024 Mar; 17(1):13-24. PubMed ID: 38278602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
    Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
    Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis.
    Lai JP; Robbins PF; Raffeld M; Aung PP; Tsokos M; Rosenberg SA; Miettinen MM; Lee CC
    Mod Pathol; 2012 Jun; 25(6):854-8. PubMed ID: 22388761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCOR-CCNB3 Fusion Positive Sarcomas: A Clinicopathologic and Molecular Analysis of 36 Cases With Comparison to Morphologic Spectrum and Clinical Behavior of Other Round Cell Sarcomas.
    Kao YC; Owosho AA; Sung YS; Zhang L; Fujisawa Y; Lee JC; Wexler L; Argani P; Swanson D; Dickson BC; Fletcher CDM; Antonescu CR
    Am J Surg Pathol; 2018 May; 42(5):604-615. PubMed ID: 29300189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Clinicopathologic and Molecular Reappraisal of GLI1 -altered Mesenchymal Tumors with Pooled Outcome Analysis Showing Poor Survival in GLI1 - amplified Versus GLI1- rearranged Tumors.
    Saoud C; Agaimy A; Dermawan JK; Chen JF; Rosenblum MK; Dickson BC; Dashti N; Michal M; Kosemehmetoglu K; Din NU; Albritton K; Agaram NP; Antonescu CR
    Am J Surg Pathol; 2024 Oct; 48(10):1302-1317. PubMed ID: 38934567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.